Advertisement

Topics

Scandinavlan Life Science venture Company Profile

01:19 EDT 24th September 2018 | BioPortfolio

SLS Venture, a Scandinavian-based venture capital company, is the result of the merger of the life science team from The Sixth Swedish National Pension Fund, Medicon Valley Capital and Innoventus. The fund is one of the largest investment funds in Scandinavia in the life science sector with approx. 270 M€ under management.The vision of SLS Venture is to become the leading Scandinavian life science investor with the aim of maximising return on investment by supporting small and mid-sized life science companies with a unique combination of capital, industrial and financial expertise.The management team at SLS Venture has a strong industrial background and an extensive collective experience of research and development, company development and growth of small and large businesses.SLS Venture believes that industrial experience and networks, that we bring to bare, are important when we, as a team, work with investments and are active owners in our portfolio companies. Experience, knowledge and understanding of the business environment surrounding a developing company are necessary and vital. Further, as international experience has shown, a strong local presence is key to success in the venture capital industry. Through our local offices we will not only generate a high quality deal flow but also be able to work closely with the portfolio companies and support them.

Location

Birger Jariagatan 10
Stockholm
SE-114 34
Sweden

Contact

Phone: 46 8 5450 7030
Fax: 46 8 5450 7039
Email: info@slsventure.com


News Articles [1871 Associated News Articles listed on BioPortfolio]

New €270M Life Science Fund Will Have a “Sharp Focus in Biotech”

Venture capitalist firm Forbion has announced the first closing of a new fund that will be investing primarily in European life science companies. Forbion Capital Partners has surpassed its goal of ...

Athenex and Xiangxue Life create joint venture Axis; Xiangxue grants TCR rights

Athenex Inc. and Xiangxue Life Science (XLS; a division of Guangzhou Xiangxue Pharmaceutical Co. Ltd.) created a 55/45 joint venture, Axis Therapeutics Ltd., to develop TCR-engineered T cells for canc...

California Life Science Sector Workforce Trends Report: Amgen, Pfizer and Genentech Leading Emplo...

The Biocom Institute and California Life Sciences Institute (CLSI) released their third biennial life science industry report. Overall, the report paints a very positive picture of the life science in...

3 Life Science IPOs in August

August brought three life science IPOs split between the New York Stock Exchange and the NASDAQ. Here we review each company for investor consideration. The post 3 Life Science IPOs in August appeared...

13 Massachusetts Life Science Companies Show Gains and Losses

Massachusetts in general and Boston, specifically Cambridge, is one of the two largest centers in the U.S. for biotech startups and life science companies (the other being the San Francisco Bay Area)....

Abingworth Raises €268M to Invest in Life Science Companies

Abingworth has raised $315M (€268M) for its most recent fund, Abingworth Bioventures VII, which invests in European and US life science companies. In the current fundraising, Abingworth surpassed i...

Life Sciences venture investing dramatically outperformed Tech venture investing over the past decade

I read with great interest a study posted on TheBij.com which talks about venture investment returns in the healthcare field: Life Sciences: The Rodney Dangerfield of Venture Capital. I’ve been...

VIDEO — Life Science Update July 2018

July was a busy month for the life science spaces–here the Investing News Network (INN) is taking a look at what some of the biggest news was for the various life science sectors. The post VIDEO —...

PubMed Articles [2253 Associated PubMed Articles listed on BioPortfolio]

Finding Meaning With Creativity in the Past, Present, and Future.

Being creative is considered a desirable trait, yet most empirical studies emphasize how to increase creativity rather than explore its possible benefits. A natural connection is how creativity can en...

Profile of Dr. Lin Lu.

Factors to consider in the verification of urinary biomarkers.

Recent Research in Science Teaching and Learning.

Is it really the "dark side" of herbal medicine?

Clinical Trials [2242 Associated Clinical Trials listed on BioPortfolio]

Improving STEM Outcomes for Young Children With Language Learning Disabilities

The sophisticated language of science can be a barrier to Science, Technology, Engineering, and Math (STEM) learning, especially for children who have specific language impairment (SLI). T...

Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females.

To assess facial acne vulgaris clinical and psychological outcomes by measuring differences in lesions counts, investigator global assessment, and subjects quality of life scores over 6 mo...

Next Science Antimicrobial Mouth Rinse Study

To assess the effect of a test antimicrobial oral rinse from Next Science on the prevention of oral biofilm formation and thereby preventing gingivitis by monitoring the oral microbial flo...

Using Focus Groups to Assess the Impact of Environmental Health Science Programs for K-12 Educational Community

The MIDAS Project (Models of Implementation and Dissemination of Environmental Health and Science Across Subjects) Assessment Objectives: - Determine whether students are aware of the ...

Safer Care for Older People in (Residential) Environments

The overall aim of the program is to advance knowledge translation science in order to improve clinical and staff related outcomes in long term care facilities (nursing homes) in western C...

Companies [2920 Associated Companies listed on BioPortfolio]

Scandinavlan Life Science venture

SLS Venture, a Scandinavian-based venture capital company, is the result of the merger of the life science team from The Sixth Swedish National Pension Fund, Medicon Valley Capital and Innoventus. The...

Frontline BioVentures

Frontline BioVentures is a China-based premier venture capital firm specializing in investments in innovative life science companies. It focuses on business within strategic life ...

Nextech Venture, L.P

Nextech Venture, L.P., founded in 1999, is a U.S. limited partnership withCHF 70 million under management and with an office in Zurich, Switzerland. We are investing in selected life science companies...

Fountain Healthcare Partners

Fountain Healthcare Partners is a life science venture capital fund with offices in Dublin, and New York. Founded in 2008, Fountain is Ireland’s largest dedicated life scienc...

Venture Valuation Inc.

Venture Valuation was founded in spring 1999 based on research work by the founder and CEO, Patrik Frei, at the University of St. Gallen (HSG) and the Swiss Federal Institute of Technology in Lausanne...

More Information about "Scandinavlan Life Science venture" on BioPortfolio

We have published hundreds of Scandinavlan Life Science venture news stories on BioPortfolio along with dozens of Scandinavlan Life Science venture Clinical Trials and PubMed Articles about Scandinavlan Life Science venture for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Scandinavlan Life Science venture Companies in our database. You can also find out about relevant Scandinavlan Life Science venture Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record